David Rabin

Fundador en

Apollo Neuroscience, Inc.

Consumer Services

Retail Trade

Finance

Perfil

David Rabin is the founder of Apollo Neuroscience, Inc., founded in 2014, and holds the title of Director.
Former job includes Venture Partner at Noetic Psychedelic.
Education history includes an undergraduate degree from Rensselaer Polytechnic Institute conferred in 2007 and a doctorate from Albany Medical College conferred in 2013.

Cargos activos de David Rabin

Empresas	Cargo	Inicio
Apollo Neuroscience, Inc. Apollo Neuroscience, Inc. Specialty StoresRetail Trade Sells wellness products through online	Fundador	01/01/2014

Todos los cargos activos de David Rabin

Antiguos cargos conocidos de David Rabin.

Empresas	Cargo	Fin
Noetic Psychedelic Noetic Psychedelic Investment ManagersFinance Noetic invests in companies located across the globe. The firm targets companies operating in the fields of across health sectors such as emerging technologies in molecular therapeutics/biotech, digital health, medical devices, and wellness. It provides financing for early stage capital requirements.	Inversor de Capital Privado	-

Ver el detalle de la experiencia de David Rabin.

Formación de David Rabin.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de David Rabin.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	4
Rensselaer Polytechnic Institute Rensselaer Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Albany Medical College Albany Medical College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Apollo Neuroscience, Inc. Apollo Neuroscience, Inc. Specialty StoresRetail Trade Sells wellness products through online	Retail Trade
Noetic Psychedelic Noetic Psychedelic Investment ManagersFinance Noetic invests in companies located across the globe. The firm targets companies operating in the fields of across health sectors such as emerging technologies in molecular therapeutics/biotech, digital health, medical devices, and wellness. It provides financing for early stage capital requirements.	Finance